These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 20675764

  • 41. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
    Kang BS, Bang MS, Jung SH.
    Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. Botulinum toxin type A for the treatment of equinus deformity in patients with mucopolysaccharidosis type II.
    Nava E, Weber P, Gautschi M, Nuoffer JM, Grunt S.
    J Child Neurol; 2012 Dec; 27(12):1611-5. PubMed ID: 22433425
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. A Critical Evaluation of the Updated Evidence for Casting for Equinus Deformity in Children with Cerebral Palsy.
    Tustin K, Patel A.
    Physiother Res Int; 2017 Jan; 22(1):. PubMed ID: 26351821
    [Abstract] [Full Text] [Related]

  • 51. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
    Balbaloglu O, Basaran A, Ayoglu H.
    J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. The short-term effects of combined modified constraint-induced movement therapy and botulinum toxin injection for children with spastic hemiplegic cerebral palsy.
    Park ES, Rha DW, Lee JD, Yoo JK, Chang WH.
    Neuropediatrics; 2009 Dec; 40(6):269-74. PubMed ID: 20446220
    [Abstract] [Full Text] [Related]

  • 57. Botulinum toxin and short-term electrical stimulation in the treatment of equinus in cerebral palsy.
    Detrembleur C, Lejeune TM, Renders A, Van Den Bergh PY.
    Mov Disord; 2002 Jan; 17(1):162-9. PubMed ID: 11835456
    [Abstract] [Full Text] [Related]

  • 58. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
    Schasfoort F, Pangalila R, Sneekes EM, Catsman C, Becher J, Horemans H, Stam HJ, Dallmeijer AJ, Bussmann JBJ.
    J Rehabil Med; 2018 Aug 22; 50(8):732-742. PubMed ID: 30080235
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity.
    Dai AI, Wasay M, Awan S.
    J Child Neurol; 2008 Dec 22; 23(12):1464-6. PubMed ID: 19073853
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.